Celltrion chairman\
Scope
Date
~
-
Shipping & Shipbuilding
HD Hyundai establishes foundation for shipyard accident victims
South Korea's HD Hyundai Co. established the HD Hyundai Hope Foundation (tentative name) to support the families of victims of major industrial acci...
Sep 02, 2024 (Gmt+09:00)
-
Corporate strategy
AI-driven shifts will unlock opportunities: SK Chairman
Challenges are ahead but the artificial intelligence industry will eventually boom, opening new markets, said South Korea’s second-largest bus...
Aug 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion scraps merger with Celltrion Pharm
South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...
Aug 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Costco sells Celltrion's Yuflyma Low WAC in US
South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...
Aug 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...
Aug 12, 2024 (Gmt+09:00)
-
Korean stock market
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Aug 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra joins US insurance-covered drug lists
South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...
Aug 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Jul 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s new plant in Songdo poised for commercial production
South Korea’s largest biosimilar maker Celltrion Inc. said on Tuesday that its third plant in Sondgo, west of Seoul, is undergoing process val...
Jul 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima SC breaks 20% market share in Europe
South Korea's biopharmaceutical company Celltrion Inc. said on Wednesday that its subcutaneous autoimmune disease treatment Remsima SC has surpassed...
Jul 17, 2024 (Gmt+09:00)
-
Electronics
Samsung Chairman Lee visits India for Ambani wedding
Samsung Electronics Co. Chairman Jay Y. Lee on Thursday visited India for the wedding of Anant Ambani — the youngest son of Asia’s riche...
Jul 12, 2024 (Gmt+09:00)
-
Leadership & Management
AI to drive Mirae Asset's next-phase growth: chairman
Mirae Asset Group is a pioneer in South Korea’s mutual fund industry. It launched the country’s first equity mutual fund in the wake of ...
Jul 03, 2024 (Gmt+09:00)
-
Leadership & Management
Kyobo Life CEO’s ethical management earns global recognition
Kyobo Life Insurance Co.'s Chairman Shin Chang-jae is internationally recognized for setting the global standard for ethical management after two de...
Jul 01, 2024 (Gmt+09:00)
-
Executive reshuffles
Lotte Group's heir apparent joins Japan holding firm's board
Shin Yoo-yeol, the heir apparent to Lotte Group, has been elected to the board of directors of its Japanese holding company, which serves as a link ...
Jun 27, 2024 (Gmt+09:00)
-
Batteries
POSCO seeks additional lithium deals from Argentina, Chile
POSCO Holdings Inc., the parent of South Korea’s top steelmaker POSCO, aims to clinch additional deals from Argentina and Chile to secure lith...
Jun 17, 2024 (Gmt+09:00)
-
Leadership & Management
LG Chairman Koo to embark on US trip to oversee battery, AI projects
Koo Kwang-mo, chair of South Korea’s fourth-largest conglomerate LG, will embark on a weeklong business trip to the US next week to seek new g...
Jun 10, 2024 (Gmt+09:00)
-
Chief Executives
Samsung’s new chip head instills a sense of crisis, hope
Samsung Electronics Co.'s new semiconductor chief Jun Young-hyun knows better than anyone about the difficulties the South Korean tech giant fa...
May 31, 2024 (Gmt+09:00)
-
Korean chipmakers
SK Hynix mulls HBM production in Japan, US
SK Hynix Inc. is investigating the possibility of building a plant for high-bandwidth memory (HBM), vital for generative artificial intelligence, in...
May 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Executive reshuffles
Samsung Electronics replaces chip head amid HBM crisis
Samsung Electronics Co., the world’s top memory chipmaker, on Tuesday replaced its semiconductor business chief as the South Korean company st...
May 21, 2024 (Gmt+09:00)
-
Pension funds
NPS to spur buyout, VC in US tech sector: chairman
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, will speed up its private equity (PE) investments ...
May 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...
May 02, 2024 (Gmt+09:00)
-
Corporate strategy
POSCO tightens belts, seeks M&A within 3 years: new chairman
Chang In-hwa, chairman and chief executive of POSCO Holdings Inc., the parent of South Korea’s top steelmaker POSCO, has vowed to take drastic...
Apr 23, 2024 (Gmt+09:00)
-
Electric vehicles
Hyundai Motor, Matrix Renewables in solar deal to power Georgia EV plant
South Korea’s top automaker Hyundai Motor Group said on Monday it has signed a 15-year power purchase contract with a US solar energy generati...
Apr 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Remsima SC in Denmark
South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...
Apr 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Korea’s Celltrion, SK Biopharmaceuticals benefit from direct US sales
Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own ma...
Apr 16, 2024 (Gmt+09:00)
-
Private equity
Hahn & Co. overhauls Namyang board, ending family control
Private equity firm Hahn & Co. on Friday won shareholder approval to replace Namyang Dairy Products Co.'s board of directors with Hahn's executi...
Mar 29, 2024 (Gmt+09:00)
-
Batteries
POSCO new chief vows to keep fostering battery materials business
POSCO Holdings Inc.'s new Chairman Chang In-hwa on Thursday pledged to keep fostering its electric vehicle battery materials business, the group&rsq...
Mar 21, 2024 (Gmt+09:00)
-
Corporate governance
Lotte Group to give more authority to outside directors
Food-to-retail conglomerate Lotte will expand the authority of outside directors by separating the roles of chief executives and board chairs at its...
Mar 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...
Mar 18, 2024 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet